Lianfang Q. Zheng

Peking Union Medical College Hospital, Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Human Equilibrative Nucleoside Transporter 1: Novel Biomarker and Prognostic Indicator for Patients with Gemcitabine-Treated Pancreatic Cancer.

Human Equilibrative Nucleoside Transporter 1: Novel Biomarker and Prognostic Indicator for Patients with Gemcitabine-Treated Pancreatic Cancer.

Journal: Cancer management and research

Published: March 28, 2024

Using a microRNA panel of circulating exosomes for diagnosis of pancreatic cancer: multicentre case-control study.

Using a microRNA panel of circulating exosomes for diagnosis of pancreatic cancer: multicentre case-control study.

Journal: The British journal of surgery

Published: June 18, 2022

HIF-1α-regulated stanniocalcin-1 mediates gemcitabine resistance in pancreatic ductal adenocarcinoma via PI3K/AKT signaling pathway.

HIF-1α-regulated stanniocalcin-1 mediates gemcitabine resistance in pancreatic ductal adenocarcinoma via PI3K/AKT signaling pathway.

Journal: Molecular carcinogenesis

Published: March 21, 2022

Correction to: MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma.

Correction to: MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 19, 2021

Novel therapies targeting hypoxia mechanism to treat pancreatic cancer.

Novel therapies targeting hypoxia mechanism to treat pancreatic cancer.

Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu

Published: June 23, 2021

Novel therapeutic strategies and perspectives for pancreatic cancer: Autophagy and apoptosis are key mechanisms to fight pancreatic cancer.

Novel therapeutic strategies and perspectives for pancreatic cancer: Autophagy and apoptosis are key mechanisms to fight pancreatic cancer.

Journal: Medical oncology (Northwood, London, England)

Published: April 08, 2021

Current epidemiology of pancreatic cancer: Challenges and opportunities.

Current epidemiology of pancreatic cancer: Challenges and opportunities.

Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu

Published: January 15, 2021

The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells.

The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells.

Journal: Cells

Published: December 14, 2020

Targeting hypoxic tumor microenvironment in pancreatic cancer.

Targeting hypoxic tumor microenvironment in pancreatic cancer.

Journal: Journal of hematology & oncology

Published: October 28, 2020

CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinoma.

CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinoma.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: October 06, 2020

Do novel treatment strategies enhance T cell-mediated Immunity: Opportunities and challenges in pancreatic cancer immunotherapy.

Do novel treatment strategies enhance T cell-mediated Immunity: Opportunities and challenges in pancreatic cancer immunotherapy.

Journal: International immunopharmacology

Published: September 23, 2020

Comparative [18F]FDG and [18F]DPA714 PET imaging and time-dependent changes of brown adipose tissue in tumour-bearing mice.

Comparative [18F]FDG and [18F]DPA714 PET imaging and time-dependent changes of brown adipose tissue in tumour-bearing mice.

Journal: Adipocyte

Published: September 09, 2020

Showing 1-12 of 38

Last Updated: 09/26/2026